Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Aclaris Therapeutics Inc. (ACRS)

1.81   -0.08 (-4.23%) 11-12 16:00
Open: 1.9 Pre. Close: 1.89
High: 1.92 Low: 1.77
Volume: 533,003 Market Cap: 75M
Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.921 - 1.934 1.934 - 1.944
Low: 1.747 - 1.759 1.759 - 1.768
Close: 1.792 - 1.812 1.812 - 1.828

Technical analysis

as of: 2019-11-12 4:25:27 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.34     One year: 2.73
Support: Support1: 1.46    Support2: 1.13
Resistance: Resistance1: 2.00    Resistance2: 2.34
Pivot: 1.77
Moving Average: MA(5): 1.79     MA(20): 1.72
MA(100): 1.56     MA(250): 4.54
MACD: MACD(12,26): 0.12     Signal(9): 0.13
Stochastic oscillator: %K(14,3): 78.04     %D(3): 70.29
RSI: RSI(14): 56.49
52-week: High: 9.85  Low: 0.74  Change(%): -81.2
Average Vol(K): 3-Month: 181217  10-Days: 80564

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ACRS has closed below upper band by 41.3%. Bollinger Bands are 65.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to ACRS's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 25 Oct 2019 13:22:39 +0000
Health Care Sector Update for 10/25/2019: ACRS, SENS, HUM, UHS, JNJ, PFE, ABT, MRK, AMGN

Fri, 11 Oct 2019 19:59:23 +0000
Health Care Sector Update for 10/11/2019: CLVS,GERN,ACRS,HEXO,HEXO.TO

Fri, 11 Oct 2019 17:41:06 +0000
Health Care Sector Update for 10/11/2019: GERN,ACRS,HEXO

Fri, 11 Oct 2019 13:20:08 +0000
Health Care Sector Update for 10/11/2019: ACRS, GERN, GILD, GLPG, JNJ, PFE, ABT, MRK, AMGN

Fri, 11 Oct 2019 09:54:17 +0000
MITO Empowered, FPRX Cuts Another 70 Jobs, Second Death In Legionnaires Outbreak

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 41.37
Shares Float (M) 27.63
% Held by Insiders 7.20
% Held by Institutions 97.14
Shares Short (K) 2970
Shares Short P. Month (K)

Stock Financials

EPS -4.784
Book Value (p.s.) 5.220
PEG Ratio
Profit Margin
Operating Margin -1678.05
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth -39.6
Gross Profit (p.s.) 0.078
Sales Per Share
EBITDA (p.s.) -3.409
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E -0.38
P/E Growth Ratio -0.04
P/BV 0.35
P/S 8.22

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.